Adrian Adams | Chairman and Chief Executive Officer |
Michael Kalb | Chief Financial Officer |
Leonard Paolillo | Chief Commercial Officer |
Rajiv Amin | Controller |
Stacy Ku | TD Cowen |
Eddie Hickman | Guggenheim Securities |
Sean Kim | Jones Trading |
Good morning, ladies and gentlemen and welcome to Impel Pharmaceuticals First Quarter 2023 Earnings and Business Update Conference Call. At this time, all participants are in a listen-only mode. Later in this call a question-and-answer session will be conducted and instructions on how to participate will be given at that time.
As a reminder, today's conference call is being recorded.
And now I would like to turn the conference over to Impel's Chairman and Chief Executive Officer, Mr.